Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Aug 28, 2026

PMVP — PMV Pharmaceuticals, Inc. Dilution Risk Tracker

Track PMVP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PMVP — Get alerts when the score changes →

As of August 28, 2026, PMV Pharmaceuticals, Inc. (PMVP) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. PMV Pharmaceuticals, Inc. has a market capitalization of $64.00M, 53.46M shares outstanding, 69 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.35 approaching $1 threshold
🔔 Track PMVP — Get forecast alerts →

Market Data

Market Cap$64.00M
Shares Outstanding53.46M
Float43.14M
Cash$79.43M
Debt$293.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 12.6% shares (2026Q1 vs prior)
69 institutional holders · 42.66M shares
#1 BML Capital Management, LLC 5.32M shares
#2 TANG CAPITAL MANAGEMENT LLC 4.25M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.95M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.38M
Days to Cover10.7
% of Float5.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual PMVP Dilution Snapshot

PMV Pharmaceuticals, Inc. (PMVP) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PMVP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PMVP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PMVP
PMVP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.